JPMorgan European Growth & Income plc (JEGI.L)
GBp 99.6
(0.4%)
GBp 99.6
(0.4%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.94 Million | 11.31 Million | 9.64 Million | 6.9 Million | 11.94 Million | 11.14 Million |
| Net Income | 76.84 Million | 43.04 Million | 36.85 Million | 9.92 Million | -64.07 Million | -1.54 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 35 Thousand | -14 Thousand | -105 Thousand | -323 Thousand | 912 Thousand | -546 Thousand |
| Other non-cash items | -483 Thousand | -31.71 Million | -27.1 Million | -2.7 Million | 75.1 Million | 13.23 Million |
| Investing Cash Flow | -2.2 Million | 9.79 Million | 4.28 Million | 3.88 Million | 39.06 Million | 3.79 Million |
| Investments in PPE | -10.78 Million | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -129.71 Million | -121.92 Million | -230.44 Million | -188.26 Million | -250.53 Million | -248.8 Million |
| Sales/Maturities of investments | 127.51 Million | 131.71 Million | 234.72 Million | 192.14 Million | 289.6 Million | 252.6 Million |
| Other Investing Activities | 33 Thousand | 9.79 Million | 4.3 Million | 3.88 Million | 2.22 Million | 862 Thousand |
| Financing Cash Flow | -19.68 Million | -25.76 Million | -15.8 Million | -33.44 Million | -26.07 Million | -15.84 Million |
| Debt repayment | - | - | - | -13.43 Million | -3.35 Million | -13.47 Million |
| Dividends payments | -13.59 Million | -22.24 Million | -9.65 Million | -9.92 Million | -13.03 Million | -11.22 Million |
| Common Stock Repurchased | -4.92 Million | -2.34 Million | -4.63 Million | -8.8 Million | -11.8 Million | -3.38 Million |
| Common Stock Issuance | - | - | - | 22.24 Million | - | - |
| Other Financing Activities | -1.15 Million | -1.17 Million | -1.52 Million | -23.52 Million | 2.12 Million | 12.23 Million |
| Accounts receivables | 2000.00 | 27 Thousand | -168 Thousand | -321 Thousand | 898 Thousand | -535 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 33 Thousand | -14 Thousand | -105 Thousand | -323 Thousand | 14 Thousand | -11 Thousand |
| Cash at beginning of period | 25.52 Million | 29.68 Million | 31.03 Million | 54.63 Million | 29.18 Million | 30.07 Million |
| Cash at end of period | 15.07 Million | 25.52 Million | 29.68 Million | 31.03 Million | 54.63 Million | 29.18 Million |
| Capital Expenditure | -10.78 Million | - | - | - | - | - |
| Effect of forex changes on cash | -509 Thousand | 494 Thousand | 528 Thousand | -939 Thousand | 505 Thousand | 10 Thousand |
| Net cash flow / Change in cash | -10.44 Million | -4.16 Million | -1.34 Million | -23.6 Million | 25.44 Million | -891 Thousand |
| Free Cash Flow | 1.15 Million | 11.31 Million | 9.64 Million | 6.9 Million | 11.94 Million | 11.14 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 38.5 Million | 76.84 Million | 38.5 Million | -3.03 Million | -1.51 Million | 43.04 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6000.00 | 35 Thousand | -6000.00 | 47 Thousand | 23.5 Thousand | -14 Thousand |
| Other non-cash items | -37.44 Million | -483 Thousand | -37.44 Million | 12.23 Million | 6.41 Million | -31.71 Million |
| Investing Cash Flow | 316 Thousand | -2.2 Million | 316 Thousand | -2.83 Million | -1.41 Million | 9.79 Million |
| Investments in PPE | -1.52 Million | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -62.19 Million | -129.71 Million | - | -67.51 Million | - | -121.92 Million |
| Sales/Maturities of investments | 62.26 Million | 127.51 Million | - | 65.21 Million | - | 131.71 Million |
| Other Investing Activities | 316 Thousand | 33 Thousand | 316 Thousand | -533 Thousand | -1.41 Million | 9.79 Million |
| Financing Cash Flow | -5.7 Million | -19.68 Million | -5.7 Million | -7.69 Million | -4.13 Million | -25.76 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -9.04 Million | -13.59 Million | -4.52 Million | -4.55 Million | -2.27 Million | -22.24 Million |
| Common Stock Repurchased | -891.5 Thousand | -4.92 Million | -891.5 Thousand | -3.14 Million | -1.57 Million | -2.34 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -291.5 Thousand | -1.15 Million | -291.5 Thousand | -288 Thousand | -288 Thousand | -1.17 Million |
| Accounts receivables | -20 Thousand | 2000.00 | - | 22 Thousand | - | 27 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6000.00 | 33 Thousand | -6000.00 | 25 Thousand | 23.5 Thousand | -14 Thousand |
| Cash at beginning of period | 23.98 Million | 25.52 Million | - | 25.52 Million | - | 29.68 Million |
| Cash at end of period | 15.07 Million | 15.07 Million | -4.45 Million | 23.98 Million | -771.5 Thousand | 25.52 Million |
| Capital Expenditure | -1.52 Million | - | - | - | - | - |
| Effect of forex changes on cash | -117 Thousand | -509 Thousand | -117 Thousand | -137.5 Thousand | -137.5 Thousand | 494 Thousand |
| Net cash flow / Change in cash | -8.9 Million | -10.44 Million | -4.45 Million | -1.54 Million | -771.5 Thousand | -4.16 Million |
| Free Cash Flow | -469 Thousand | 11.94 Million | 1.05 Million | 9.26 Million | 4.92 Million | 11.31 Million |
2791
MED
0MN5
5367
3297
CPHI